Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.

Chang, Y-C; Chuang, L-M; Lin, J-W; Chen, S-T; Lai, M-S; Chang, C-H

Chang, Y-C; Chuang, L-M; Lin, J-W; Chen, S-T; Lai, M-S; Chang, C-H.

Affiliation

Chang YC; Graduate Institute of Medical Genomics and Proteomics, National Taiwan University, Taipei, Taiwan.
Chuang LM; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Lin JW; Department of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen ST; Department of Internal Medicine, National Taiwan University Hospital HsinChu branch, HsinChu, Taiwan.
Lai MS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chang CH; Department of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Diabet Med ; 32(11): 1460-9, 2015 Nov.

Article in En | MEDLINE | ID: mdl-25970814

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Diabetic Angiopathies / Diabetic Cardiomyopathies / Hypoglycemic Agents / Metformin Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2015 Document type: Article Affiliation country: Taiwán Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google